Freeline Therapeutics Holdings plc - ADR

NASDAQ:FRLN   2:19:57 PM EDT
0.58
-0.02 (-2.50%)
4:08:20 PM EDT: $0.59 +0.01 (+1.05%)
Earnings Announcements

Freeline Reports Q3 2022 Financial Results

Published: 11/15/2022 12:30 GMT
Freeline Therapeutics Holdings plc - ADR (FRLN) - Freeline Reports Third Quarter 2022 Financial Results and Corporate Update.
Freeline Therapeutics Holdings Plc - Streamlining Organization and Extending Cash Runway Into 2024.
Freeline Therapeutics Holdings - Entered Into Deal to Sell Unit, Freeline Therapeutics Gmbh, Certain Related Intellectual Property to Ascend for $25 Million.
Freeline Therapeutics Holdings Plc - Company is Reducing Its US and Uk Workforce by Approximately 30 Employees.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.27

Next Quarter Revenue Guidance is expected to be $5 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.